Emergency medical services arrive at the emergency department with a 45-year-old man who has been experiencing a continuous generalized tonic-clonic seizure for the past 15 minutes. Upon evaluation, the patient remains unresponsive with rhythmic motor jerking of all four extremities. His airway is patent with spontaneous respirations, and a point-of-care capillary blood glucose is 98 mg/dL. The nursing staff has successfully secured intravenous access. Arrange the following pharmacologic interventions in the required chronological sequence for the escalating management of this patient's condition.
- 1Intravenous lorazepam
- 2Intravenous fosphenytoin
- 3Intravenous propofol
Answer
The correct sequence for managing status epilepticus is to administer intravenous lorazepam first, followed by intravenous fosphenytoin, and finally escalate to an intravenous propofol continuous infusion if necessary.
Status epilepticus is a life-threatening neurologic emergency requiring strict adherence to a stepwise pharmacologic algorithm. Phase 1 management (0 to 20 minutes) consists of rapid-acting benzodiazepines, such as intravenous lorazepam, to immediately abort the seizure. Phase 2 management (20 to 40 minutes) involves administering a longer-acting non-benzodiazepine antiseizure medication, such as fosphenytoin, valproic acid, or levetiracetam, to maintain seizure control or treat benzodiazepine-refractory activity. Phase 3 management (40 to 60 minutes) addresses refractory status epilepticus and requires escalation to continuous anesthetic infusions, such as propofol, midazolam, or pentobarbital. These Phase 3 agents induce profound respiratory and hemodynamic depression, mandating concurrent endotracheal intubation.
Step-by-Step Solution
Key Concept
The evidence-based pharmacologic management of status epilepticus requires a protocolized escalation from rapid-acting benzodiazepines, to longer-acting antiseizure medications, and ultimately to continuous general anesthetic infusions.
Estimated Time:1m 0s